NCT06058728View on ClinicalTrials.gov

A Study to Evaluate Changes in Hair in Adult Participants Taking Oral Oriahnn Capsules With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

December 20, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Uterine Fibroids (UF)
Trial Locations (1)

22201-5330

Dorsata /ID# 252675, Arlington

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY